Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-03 05:41:08 - browse：777

Colorful broken DNA helix genome. -- health coverage from STAT — Adobe

In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies raised over $300 million off an audacious promise: It was going to license and develop gene therapies for at least 18 different rare and serious neurological diseases.

The effort brought hope for many rare disease families, some of whom had raised money to fund the UT-Southwestern scientist who designed the treatments after they saw no other options for their children.

Last week, the grand plan took perhaps a final blow. Taysha announced it would discontinue development of a treatment for giant axonal neuropathy, or GAN, a fatal, degenerative disease known to affect fewer than 100 people worldwide. The FDA, Taysha said, had requested an additional clinical trial that would be infeasible.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： How to protect patients from sexual assault

leisure time

WSS

Crinetics acromegaly drug succeeds in late

Listen: Biogen's potential pivot, & Illumina's next chapter

The EU Joint Clinical Assessment needs to live up to its promise

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Impact of Dobbs ruling felt at reproductive medicine meeting

Crinetics acromegaly drug succeeds in late

entertainment

Wikipedia

hotspot

Hollywood unions extend contract negotiations for actors

Why Novartis is changing the name of its research labs

Virginia high school admissions case could be legal follow

CEOs share strategies for surviving biotech slump

Alkermes shareholders re

STAT Readout Newsletter: Today's biggest biotech updates

Medicare details structure of new drug price negotiation program

Hospital price transparency does save money, advocate argues

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Trump surgeon general acknowledges mistakes during Covid

focus

Ethical issues complicate the benefits of medical crowdfunding

Why Novartis is changing the name of its research labs

Ethical issues complicate the benefits of medical crowdfunding

What drug price negotiations mean for Medicare Part D

2023 STAT Wunderkinds: get to know the winners

STAT Summit: GSK CEO on pharma giant's new direction

leisure time

leisure time

leisure time

Wikipedia